Medpace Holdings (MEDP) Consolidated Net Income (2015 - 2026)
Medpace Holdings' (MEDP) quarterly Consolidated Net Income came in at $121.4 million in Q2 2026, up 34.46% YoY from $90.3 million in Q2 2025, and down 2.02% on a QoQ basis from $123.9 million in Q1 2026.
Medpace Holdings (MEDP) Consolidated Net Income (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has 12 years of Consolidated Net Income data on file, last reported at $121.4 million in Q2 2026.
- Quarterly Consolidated Net Income rose 34.46% year-over-year to $121.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $491.5 million (up 17.5% YoY) and the FY2025 annual result came in at $451.1 million, up 11.56% from the prior year.
- Consolidated Net Income eased to $121.4 million in Q2 2026, from $123.9 million in the prior quarter.
- In the past five years, Consolidated Net Income ranged from a high of $135.1 million in Q4 2025 to a low of $49.4 million in Q2 2022.
- A 5-year average of $90.5 million and a median of $89.3 million in 2024 frame the typical range for Consolidated Net Income.
- Annual changes were most pronounced in 2024 — Consolidated Net Income surged 49.45% — and 2025, when it rose 2.16%.
- Tracing MEDP's Consolidated Net Income over 5 years: stood at $68.7 million in 2022, then climbed by 14.02% to $78.3 million in 2023, then surged by 49.45% to $117.0 million in 2024, then increased by 15.48% to $135.1 million in 2025, then fell by 10.19% to $121.4 million in 2026.
- The last three Consolidated Net Income figures came in at $121.4 million (Q2 2026), $123.9 million (Q1 2026), and $135.1 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.78 Bn | 209.71 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 139.83 Bn | 135.48 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Idexx Laboratories | 45.99 Bn | 45.79 Bn | 779.09 Mn | 338.41 Mn |
| 4 | Agilent Technologies | 39.69 Bn | 37.88 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 39.31 Bn | 37.23 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Natera | 38.74 Bn | 37.64 Bn | 696.04 Mn | -85.11 Mn |
| 7 | Illumina | 29.94 Bn | 28.77 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.55 Bn | 28.50 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Quest Diagnostics | 26.18 Bn | 25.55 Bn | 1.03 Bn | 324.00 Mn |
| 10 | Medpace Holdings | 16.44 Bn | 15.94 Bn | 201.64 Mn | 121.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 121.36 Mn |
| Mar 31, 2026 | 123.87 Mn |
| Dec 31, 2025 | 135.13 Mn |
| Sep 30, 2025 | 111.14 Mn |
| Jun 30, 2025 | 90.26 Mn |
| Mar 31, 2025 | 114.60 Mn |
| Dec 31, 2024 | 117.02 Mn |
| Sep 30, 2024 | 96.43 Mn |
| Jun 30, 2024 | 88.35 Mn |
| Mar 31, 2024 | 102.59 Mn |
| Dec 31, 2023 | 78.30 Mn |
| Sep 30, 2023 | 70.55 Mn |
| Jun 30, 2023 | 61.07 Mn |
| Mar 31, 2023 | 72.89 Mn |
| Dec 31, 2022 | 68.67 Mn |
| Sep 30, 2022 | 66.03 Mn |
| Jun 30, 2022 | 49.36 Mn |
| Mar 31, 2022 | 61.31 Mn |
| Dec 31, 2021 | 50.03 Mn |
| Sep 30, 2021 | 48.57 Mn |